Hence, we aimed to evaluate if quantifiable parameters could be established for the expression of CD44, EGFR, vimentin, and E-cadherin in terms of predicting tumor aggressiveness and prognostic significance, if any, in OSCC. The gene discussed is CD44; the disease is neoplasm.